Skin Biopsy and Patient-Specific Stem Cell Lines
- 4 July 2015
- book chapter
- Published by Springer Nature
- Vol. 1353, 77-88
Abstract
The generation of patient-specific induced pluripotent stem (iPS) cells permits the development of next-generation patient-specific systems biology models reflecting personalized genomics profiles to better understand pathophysiology. In this chapter, we describe how to create a patient-specific iPS cell line. There are three major steps: (1) performing a skin biopsy procedure on the patient; (2) extracting human fibroblast cells from the skin biopsy tissue; and (3) reprogramming patient-specific fibroblast cells into the pluripotent stem cell stage.Keywords
This publication has 9 references indexed in Scilit:
- Gene Therapy in Patient-specific Stem Cell Lines and a Preclinical Model of Retinitis Pigmentosa With Membrane Frizzled-related Protein DefectsMolecular Therapy, 2014
- Validation of genome-wide association study (GWAS)-identified disease risk alleles with patient-specific stem cell linesHuman Molecular Genetics, 2014
- iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degenerationHuman Molecular Genetics, 2012
- Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genomeProceedings of the Japan Academy, Series B, 2009
- Generation of human-induced pluripotent stem cellsNature Protocols, 2008
- Generation of germline-competent induced pluripotent stem cellsNature, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- A Cytoplasmic RNA Vector Derived from Nontransmissible Sendai Virus with Efficient Gene Transfer and ExpressionJournal of Virology, 2000
- Isolation of a Virus from a Sporadic Case of Izumi FeverThe Tohoku Journal of Experimental Medicine, 1953